Daveen Chopra Biography and Net Worth

Daveen Chopra has been corporate vice president, Surgical Structural Heart since May 2018. Chopra has broad experience in the medical technology industry, including global leadership in strategy, marketing, commercial operations, research and development, and program management. Prior to joining Edwards, Chopra held various roles with increasing levels of responsibility at Medtronic, plc, from 2005 to 2018, culminating in a global leadership role as vice president and general manager of its aortic franchise. Chopra previously served as vice president of global marketing leading Medtronic’s endovascular therapies business. While in Medtronic’s endovascular therapies business, he served as vice president, U.S. commercial operations, director of program management office, senior business manager for the endovascular and peripheral business in Asia-Pacific, global group product manager for thoracic stent grafts, and international aortic product manager. Prior to Medtronic, Chopra served as an international strategy consultant at The Parthenon Group supporting clients in various industries ranging from education to industrial manufacturing. In 2020, he joined the board of the Edwards Lifesciences Foundation, and, in 2021, he joined the board of Octane. Chopra earned a dual bachelor’s degree in economics and biology from Duke University, and a masters from Harvard Business School, where he graduated with honors.

What is Daveen Chopra's net worth?: The estimated net worth of Daveen Chopra is at least $2.19 million as of August 20th, 2024. Mr. Chopra owns 29,333 shares of Edwards Lifesciences stock worth more than $2,194,402 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Chopra may own. Learn More about Daveen Chopra's net worth.
How do I contact Daveen Chopra?: The corporate mailing address for Mr. Chopra and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Daveen Chopra's contact information.
Has Daveen Chopra been buying or selling shares of Edwards Lifesciences?: Daveen Chopra has not been actively trading shares of Edwards Lifesciences during the last ninety days. Most recently, Daveen Chopra sold 1,250 shares of the business's stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $69.95, for a transaction totalling $87,437.50. Following the completion of the sale, the vice president now directly owns 29,333 shares of the company's stock, valued at $2,051,843.35. Learn More on Daveen Chopra's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 34 times. They sold a total of 377,713 shares worth more than $31,439,247.64. The most recent insider tranaction occured on December, 16th when VP Daniel J Lippis sold 2,500 shares worth more than $185,200.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 12/16/2024.

Daveen Chopra Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2024	Sell	1,250	$69.95	$87,437.50	29,333
2/21/2024	Sell	8,200	$86.74	$711,268.00	22,750
12/15/2023	Sell	7,000	$78.25	$547,750.00	23,950
12/6/2023	Sell	3,500	$70.00	$245,000.00	23,950
10/3/2023	Sell	8,500	$70.00	$595,000.00	23,950
9/6/2023	Sell	8,500	$76.07	$646,595.00	23,950
8/29/2023	Sell	1,500	$76.69	$115,035.00	23,950
3/15/2023	Sell	4,435	$77.47	$343,579.45	18,911
2/15/2023	Sell	4,000	$76.01	$304,040.00	18,911
1/17/2023	Sell	4,000	$78.00	$312,000.00	18,911
12/15/2022	Sell	4,000	$74.80	$299,200.00	18,911
11/15/2022	Sell	4,000	$74.18	$296,720.00	18,911
10/14/2022	Sell	4,000	$84.77	$339,080.00	18,911
8/2/2022	Sell	1,000	$102.49	$102,490.00	18,911
5/26/2022	Sell	1,000	$98.31	$98,310.00	19,911

Daveen Chopra Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $74.81

$72.97

$75.27

50 Day Range

MA: $70.06

$65.75

$74.81

2 Week Range

Now: $74.81

$58.93

$96.12

Volume

14,033,775 shs

Average Volume

4,725,668 shs

Market Capitalization

$44.12 billion

P/E Ratio

10.80

Dividend Yield

N/A

Beta

1.12

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.